EN PL

EMEA: Guideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials

18.03.2010
This guideline outlines the requirements for data to be presented on the biological, chemical and pharmaceutical quality of Investigational Medicinal Products (IMP) containing biological/biotechnology derived substances.